(Q36025968)

11 August 2017

1 reference

title

Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk (English)

1 reference

11 August 2017

1 reference

coronary artery disease

1 reference

inferred from title

author

Christie M. Ballantyne

series ordinal

2

object named as

Christie M Ballantyne

1 reference

11 August 2017

1

Vijay Nambi

1 reference

11 August 2017

publication date

1 February 2005

1 reference

Current Atherosclerosis Reports

11 August 2017

published in

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

22-28

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-005-0071-8

11 August 2017

exact match

0 references

cites work

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Novel inflammatory markers of coronary risk: theory versus practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0071-8

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

12 December 2020

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.

1 reference

12 December 2020

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

1 reference

12 December 2020

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

12 December 2020

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

1 reference

12 December 2020

CRP as a mediator of disease

1 reference

12 December 2020

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

12 December 2020

Inflammatory pathways in atherosclerosis and acute coronary syndromes

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma

1 reference

12 December 2020

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

12 December 2020

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

1 reference

12 December 2020

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

12 December 2020

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

1 reference

12 December 2020

Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

1 reference

12 December 2020

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

1 reference

12 December 2020

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

1 reference

12 December 2020

10.1007/S11883-005-0071-8

Identifiers

DOI

1 reference

11 August 2017

1 reference